Clinical Trials Browser

Has results × Colorectal Neoplasms × nintedanib × Clear all

NCT02780700 2025-02-03

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Phase 2 Terminated

1 enrolled 5 charts

Gastrointestinal

Colorectal Neoplasms

NCT02149108 2017-07-21

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Phase 3 Completed

768 enrolled 10 charts

Gastrointestinal

Colorectal Neoplasms

NCT00904839 2015-02-04

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Phase 2 Completed

128 enrolled 21 charts

Gastrointestinal

Colorectal Neoplasms